Medpace draws on both internal and external resources for its leadership and direction. Currently serving on the Board of Directors are:
August J. Troendle, MD
President and CEO, Medpace, Inc.
Chairman
Fred B. Davenport, Jr., JD, MBA
Partner of the law firm Murchison, Taylor & Gibson
Scott P. Kadish, JD
Partner of the law firm Ulmer and Berne LLP
Thomas C. King, MD, PhD, FCAP
Associate Professor, Department of Pathology and Laboratory Medicine, Boston University School of Medicine Medical Director, Department of Pathology, The William W. Backus Hospital
Neal McCarthy, JD
CEO, Fairmount Partners, an investment banking and capital advisory firm
Paul J. Sobel, CPA, CIA
Vice President, Internal Audit, Mirant Corporation, an energy company
Evan Stein, MD, PhD
Chief Scientific Officer and US Laboratory Director, Medpace Reference Laboratories; Director, Metabolic and Atherosclerosis Research Center; Volunteer Professor, Pathology and Laboratory Medicine, University of Cincinnati Medical
Officers
August J. Troendle, MD
President
Jonathan L. Isaacsohn, MD, FACC
Executive
Vice President
Jeff Martini, BSBA, CPA
Treasurer
Kay Cody Nolen, JD, MBA
Secretary